Legis Daily

Prescription Pricing for the People Act of 2021

USA117th CongressS-1388| Senate 
| Updated: 7/29/2021
Chuck Grassley

Chuck Grassley

Republican Senator

Iowa

Cosponsors (10)
Joni Ernst (Republican)Tommy Tuberville (Republican)Mike Braun (Republican)Thomas Tillis (Republican)Marsha Blackburn (Republican)John Boozman (Republican)James Lankford (Republican)Maria Cantwell (Democratic)Richard Blumenthal (Democratic)Shelley Moore Capito (Republican)

Judiciary Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Prescription Pricing for the People Act of 20 21 This bill requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescription drugs. The FTC also must provide recommendations to increase transparency in the supply chain and prevent anticompetitive practices.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

S 116-1227
Prescription Pricing for the People Act of 2019
Apr 27, 2021
Introduced in Senate
Apr 27, 2021
Read twice and referred to the Committee on the Judiciary.
Jul 29, 2021
Committee on the Judiciary. Ordered to be reported without amendment favorably.

  • Bill from Previous Congress

    S 116-1227
    Prescription Pricing for the People Act of 2019
  • April 27, 2021
    Introduced in Senate
  • April 27, 2021
    Read twice and referred to the Committee on the Judiciary.
  • July 29, 2021
    Committee on the Judiciary. Ordered to be reported without amendment favorably.

Commerce

Business ethicsBusiness recordsCivil actions and liabilityCompetition and antitrustCongressional oversightConsumer affairsHealth care costs and insuranceHealth information and medical recordsInflation and pricesManufacturingPrescription drugsRetail and wholesale trades

Prescription Pricing for the People Act of 2021

USA117th CongressS-1388| Senate 
| Updated: 7/29/2021
Prescription Pricing for the People Act of 20 21 This bill requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescription drugs. The FTC also must provide recommendations to increase transparency in the supply chain and prevent anticompetitive practices.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

S 116-1227
Prescription Pricing for the People Act of 2019
Apr 27, 2021
Introduced in Senate
Apr 27, 2021
Read twice and referred to the Committee on the Judiciary.
Jul 29, 2021
Committee on the Judiciary. Ordered to be reported without amendment favorably.

  • Bill from Previous Congress

    S 116-1227
    Prescription Pricing for the People Act of 2019
  • April 27, 2021
    Introduced in Senate
  • April 27, 2021
    Read twice and referred to the Committee on the Judiciary.
  • July 29, 2021
    Committee on the Judiciary. Ordered to be reported without amendment favorably.
Chuck Grassley

Chuck Grassley

Republican Senator

Iowa

Cosponsors (10)
Joni Ernst (Republican)Tommy Tuberville (Republican)Mike Braun (Republican)Thomas Tillis (Republican)Marsha Blackburn (Republican)John Boozman (Republican)James Lankford (Republican)Maria Cantwell (Democratic)Richard Blumenthal (Democratic)Shelley Moore Capito (Republican)

Judiciary Committee

Commerce

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Business ethicsBusiness recordsCivil actions and liabilityCompetition and antitrustCongressional oversightConsumer affairsHealth care costs and insuranceHealth information and medical recordsInflation and pricesManufacturingPrescription drugsRetail and wholesale trades